Publications by authors named "Micaela Robotti"

Claim this Profile
P
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, Massimo Autunno, Francesca Pistoia, Micaela Robotti

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d'Onofrio, Cinzia Aurilia, Micaela Robotti

Neurol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d'Onofrio, Cinzia Aurilia, Micaela Robotti

Neurol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo D'Onofrio, Micaela Robotti

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo D'Onofrio, Micaela Robotti

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
Matteo Castaldo, Marta Waliszewska-Prosół, Maria Koutsokera, Micaela Robotti, Marcin Straburzyński

J Headache Pain· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities of primary headache disorders: a literature review with meta-analysis.
Valeria Caponnetto, Manuela Deodato, Micaela Robotti, Maria Koutsokera, Valeria Pozzilli

J Headache Pain· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.
Chiara Zanetta, Micaela Robotti, Agostino Nozzolillo, Francesca Sangalli, Giuseppe Liberatore

J Neurol Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation.
Vittorio Martinelli, Gloria Dalla Costa, Francesca Sangalli, Bruno Colombo, Micaela Robotti

Mult Scler Relat Disord· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis